Shiratori Pharmaceutical

About Shiratori Pharmaceutical

Shiratori Pharmaceutical is an API manufacturer in Japan focusing on APIs in niche markets such as rare diseases, rare oncology, neurology, etc. including high potency APIs. Manufacturing patents have been applied for Tafamidis and Eltrombopag in Japan.
Please find API pipeline below:
- Trametinib
- Cabazitaxel Acetonate
- Opicapone
- Ixazomib Citrate
- Brexpiprazole
- Valbenazine Tosilate
- Esaxerenone
- Pemafibrate
- Omidenepag
- Daprodustat- Macitentan
- Riociguat
- Selexipag
- Tafamidis

Certifications
  • JP
  • 2020
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
API Producer
Contact info
  • JBSL Kanda Building 7F, 12 Kanda Higashi Matsushita, 101-0042, Chiyoda-ku, Tokyo-to, Japan
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from Shiratori Pharmaceutical (5)